People · Operator
Named in public records as an officer, director or promoter · active 2015–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alastin Skincare, Inc. | — | Biotechnology | Series A | $31.4M | $357.2M | 2015 |
Lynn S. Salo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lynn S. Salo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cam L. Garner | 1 | 11 |
| Scott L. Glenn | 1 | 9 |
| William R. LaRue | 1 | 3 |
| Ann D. Rhoads | 1 | 2 |
| Diane S. Goostree | 1 | 2 |
| Maryanne K. Sorge | 1 | 1 |
| Mark G. Rubin | 1 | 1 |
| Lynn S. Solo | 1 | 1 |
| Elisabeth S. Sandoval | 1 | 1 |
| Tom K. Christenson | 1 | 1 |
| Ted L. Schwarz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.